|Bid||0.0000 x 21500|
|Ask||0.0000 x 42300|
|Day's Range||1.7900 - 1.8900|
|52 Week Range||0.3500 - 5.5600|
|Beta (5Y Monthly)||0.41|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 13, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.30|
Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Of course, a low share price doesn't necessarily mean a stock is cheap. A high share price doesn't necessarily mean a stock is expensive, either. In many cases, penny stocks (which today include any stock with a share price below $5) are actually valued unattractively.
Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its first quarter 2021 financial results after market close on Thursday, May 13, 2021.